Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 15 studies | 43% ± 16% | |
epithelial cell | 4 studies | 34% ± 17% | |
deuterosomal cell | 3 studies | 20% ± 0% |
Insufficient scRNA-seq data for expression of ENDOG at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 258.60 | 1438 / 1445 | 100% | 15.29 | 183 / 183 |
prostate | 100% | 271.58 | 244 / 245 | 97% | 8.45 | 487 / 502 |
stomach | 98% | 247.54 | 352 / 359 | 98% | 18.43 | 280 / 286 |
brain | 99% | 303.63 | 2605 / 2642 | 97% | 9.24 | 683 / 705 |
ovary | 94% | 146.39 | 170 / 180 | 100% | 18.73 | 430 / 430 |
liver | 100% | 414.91 | 226 / 226 | 94% | 7.14 | 382 / 406 |
bladder | 100% | 224.19 | 21 / 21 | 92% | 9.29 | 464 / 504 |
intestine | 91% | 218.30 | 882 / 966 | 95% | 17.29 | 503 / 527 |
uterus | 95% | 152.17 | 162 / 170 | 91% | 6.33 | 416 / 459 |
thymus | 99% | 230.62 | 644 / 653 | 86% | 5.30 | 519 / 605 |
adrenal gland | 100% | 319.54 | 258 / 258 | 81% | 4.42 | 186 / 230 |
kidney | 100% | 357.84 | 89 / 89 | 80% | 5.30 | 718 / 901 |
skin | 99% | 231.63 | 1789 / 1809 | 80% | 4.13 | 379 / 472 |
pancreas | 99% | 217.69 | 324 / 328 | 80% | 4.33 | 143 / 178 |
lung | 94% | 190.57 | 546 / 578 | 81% | 5.25 | 938 / 1155 |
breast | 98% | 225.79 | 452 / 459 | 75% | 3.94 | 835 / 1118 |
eye | 0% | 0 | 0 / 0 | 100% | 12.33 | 80 / 80 |
muscle | 100% | 1248.66 | 803 / 803 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 8.02 | 1 / 1 |
blood vessel | 98% | 199.17 | 1310 / 1335 | 0% | 0 | 0 / 0 |
spleen | 98% | 165.28 | 236 / 241 | 0% | 0 | 0 / 0 |
adipose | 97% | 193.96 | 1167 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 8.68 | 28 / 29 |
heart | 96% | 479.44 | 826 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 93% | 5.89 | 42 / 45 |
peripheral blood | 72% | 108.71 | 672 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0001701 | Biological process | in utero embryonic development |
GO_0090297 | Biological process | positive regulation of mitochondrial DNA replication |
GO_0032007 | Biological process | negative regulation of TOR signaling |
GO_0006974 | Biological process | DNA damage response |
GO_0034612 | Biological process | response to tumor necrosis factor |
GO_0010508 | Biological process | positive regulation of autophagy |
GO_0046677 | Biological process | response to antibiotic |
GO_0006310 | Biological process | DNA recombination |
GO_0006309 | Biological process | apoptotic DNA fragmentation |
GO_0043065 | Biological process | positive regulation of apoptotic process |
GO_0032043 | Biological process | mitochondrial DNA catabolic process |
GO_0005739 | Cellular component | mitochondrion |
GO_0005743 | Cellular component | mitochondrial inner membrane |
GO_0005634 | Cellular component | nucleus |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0004521 | Molecular function | RNA endonuclease activity |
GO_0003676 | Molecular function | nucleic acid binding |
GO_0000287 | Molecular function | magnesium ion binding |
GO_0004520 | Molecular function | DNA endonuclease activity |
GO_0000014 | Molecular function | single-stranded DNA endodeoxyribonuclease activity |
GO_0005515 | Molecular function | protein binding |
Gene name | ENDOG |
Protein name | Endonuclease G, mitochondrial (Endo G) (EC 3.1.30.-) |
Synonyms | |
Description | FUNCTION: Endonuclease that preferentially catalyzes the cleavage of double-stranded 5-hydroxymethylcytosine (5hmC)-modified DNA . The 5hmC-modified nucleotide does not increase the binding affinity, but instead increases the efficiency of cutting and specifies the site of cleavage for the modified DNAs (By similarity). Shows significantly higher affinity for four-stranded Holliday junction over duplex and single-stranded DNAs (By similarity). Promotes conservative recombination when the DNA is 5hmC-modified . Promotes autophagy through the suppression of mTOR by its phosphorylation-mediated interaction with YWHAG and its endonuclease activity-mediated DNA damage response . GSK3-beta mediated phosphorylation of ENDOG enhances its interaction with YWHAG, leading to the release of TSC2 and PIK3C3 from YWHAG resulting in mTOR pathway suppression and autophagy initiation . Promotes cleavage of mtDNA in response to oxidative and nitrosative stress, in turn inducing compensatory mtDNA replication . . |
Accessions | ENST00000372642.5 Q14249 |